Last reviewed · How we verify
NCT07467408
Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU)
trial testing High-Intensity Focused Ultrasound of the medial lumbar branch in Lumbago in 60 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | Consorci Sanitari de Terrassa |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 April 2026 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- High-Intensity Focused Ultrasound of the medial lumbar branch
Conditions studied
- Lumbago — all drugs for Lumbago →
Sponsor
Consorci Sanitari de Terrassa — full company profile →
Who can join
18 and older, any sex, with Lumbago. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High-intensity focused ultrasound (HIFU) is an emerging technology that allows for the targeted thermal ablation of deep tissues in a non-invasive manner, by concentrating acoustic energy on the target nerve, whilst preserving adjacent structures. Recently, open clinical studies have confirmed the feasibility, safety and efficacy of HIFU in patients with lumbar facet syndrome, with clinical response rates similar to those of RFA and no significant complications. This observational, prospective, non-interventional study aims to evaluate the clinical efficacy of lumbar medial branch ablation using this technique at 1, 3 and 6 months, as well as to assess patient satisfaction with the procedure. Only clinical data from patients undergoing the procedure in routine clinical practice will be collected.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07467408
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lumbago
Currently open trials in the same condition.
- NCT05923736 — Cardiovascular Risk in Digital Osteoarthritis · NA · recruiting
Other Consorci Sanitari de Terrassa trials
Trials by the same sponsor.
- NCT07210892 — Paramedian Incidence Angles in Spinal Anaesthesia · recruiting
- NCT06956794 — Multimodal Training With Immersive Virtual Reality to Improve the Cognitive Health and Emotional Well-being of Older Wom · NA · active not recruiting
- NCT06713460 — Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM) · NA · recruiting
- NCT07040748 — Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome · NA · recruiting
- NCT06492590 — Long COVID-19 Intervention (COVIDL/MIQoL) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07467408 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Consorci Sanitari de Terrassa
- Last refreshed: 16 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07467408.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing